erectile dysfunction: Persistent or recurrent inability to achieve or to maintain an erection during sexual activity.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleonly males |
244368 |
2. Check conditions
|
244216 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
3427 |
4. Check minimum number of events
Min. number of events
3
|
3427 |
5. Include endpointsNone |
3427 |
6. Filter based on genotype QC (FinnGen only) |
3055 |
Control definitions (FinnGen only)
- Control conditions
- not ERECTILE_EXCLUSION
Extra metadata
- First used in FinnGen datafreeze
- DF4
Erectile dysfunction
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 18178 | - | 18178 |
| Only index persons | 15195 | - | 15195 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.51 | - | 0.51 |
| Only index persons | 0.58 | - | 0.58 |
| Median age at first event (years) | |||
| Whole population | - | - | 61.18 |
| Only index persons | - | - | 60.48 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3055 | - | 3055 |
| Unadjusted period prevalence (%) | 1.40 | - | 1.40 |
| Median age at first event (years) | 61.11 | - | 61.11 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3161
- Matched controls
- 31610
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
214.2
307.7
1816
198
G04BE01
ATC
alprostadil; parenteral, urethral
338.9
307.7
2128
191
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
29.5
307.7
681
292
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
13.1
307.7
663
627
C61
ICD-10 Finland
Malignant neoplasm of prostate
7.8
307.7
1769
4408
G04BE03
ATC
sildenafil; oral
367.7
307.7
1619
90
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
8.2
307.7
1750
4165
G04BE04
ATC
yohimbine; oral
30.4
307.7
384
143
G04BE30
ATC
drugs used in erectile dysfunction - combinations
528.2
307.7
375
8
G04BX05, ,
ATC
43.0
307.7
403
107
ZXC96
NOMESCO Finland
Robot assisted procedure
8.7
306.7
418
546
V03AX01
ATC
[D]nalfurafine; oral
12.7
288.1
290
249
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
24.5
264.0
189
82
J01EA01
ATC
trimethoprim; systemic
3.9
238.9
901
2913
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
10.3
202.6
233
242
XKG00
NOMESCO Finland
Artificial induction of erection
43.3
202.5
121
29
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
4.1
194.7
635
1831
N39.3
ICD-10 Finland
Stress incontinence
12.6
193.5
193
162
XKD00
NOMESCO Finland
Uroflowmetry
2.9
182.9
1450
7144
N48.4
ICD-10 Finland
Impotence of organic origin
5.8
180.6
353
667
G04BE09
ATC
vardenafil; oral
312.5
174.8
176
6
G04BE08
ATC
tadalafil; oral
234.2
173.2
177
8
116
Kela drug reimbursment
Prostate cancer
3.4
160.7
725
2569
KC1GB
NOMESCO Finland
Cystography with X-ray
9.4
160.5
196
220
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.7
136.7
485
1462
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.1
114.9
582
2174
XJH00
NOMESCO Finland
Transanal ultrasonography
3.0
111.8
608
2360
KDE20
NOMESCO Finland
Removal of foreign body from urethra
7.8
110.7
157
211
UKC02
NOMESCO Finland
Cystoscopy
2.4
108.6
1086
5672
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
2.9
108.5
633
2549
L02BB03
ATC
bicalutamide; oral
3.8
104.2
341
965
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
102.4
1085
5782
G03BB01
ATC
mesterolone; oral
8.9
100.6
127
148
Z94.1
ICD-10 Finland
Heart transplant status
32.6
99.3
64
20
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
9.9
91.7
106
110
B01AB05
ATC
enoxaparin; parenteral
2.2
90.6
1233
7203
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
80.6
664
3125
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.1
78.6
1028
5846
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
6.1
78.3
139
237
KD1GB
NOMESCO Finland
Uretrocystogpaphy with X-ray
13.5
69.1
65
49
N02AX02
ATC
tramadol; systemic, rectal
1.9
65.5
1570
10840
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
15.0
63.1
56
38
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
14.1
62.2
57
41
FXL00
NOMESCO Finland
Insertion and use of extra-, para- or intracorporeal VAD
99.3
62.1
68
7
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
60.6
1234
8028
Y77
ICPC
Malignant neoplasm prostate
2.8
59.7
326
1246
J01MA02
ATC
ciprofloxacin; systemic
1.8
58.1
1509
10545
KDG43
NOMESCO Finland
Transobturatorial sling urethrocystopexy
15.5
56.3
49
32
WX740
NOMESCO Finland
Nitrogen oxide therapy
90.4
56.1
62
7
XKD03
NOMESCO Finland
Urethral pressure profilometry
6.0
53.5
96
165
KDK10
NOMESCO Finland
Implantation of artificial urinary sphincter around bulbar urethra
15.5
52.9
46
30
WF090
NOMESCO Finland
Profylactic radiotherapy
6.6
52.4
85
132
109
Kela drug reimbursment
Multiple sclerosis
13.6
50.2
47
35
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
49.7
555
2908
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
107.8
48.9
53
5
U04
ICPC
Incontinence urine
2.8
48.6
256
957
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
12.0
45.5
46
39
G04BD07
ATC
tolterodine; oral
3.2
45.3
192
635
G04BD08
ATC
solifenacin; oral
2.6
45.3
289
1190
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
16.0
44.4
38
24
G35
ICD-10 Finland
Multiple sclerosis
8.1
44.0
59
74
N05CF01
ATC
zopiclone; oral
1.7
43.7
1039
6922
NK6AN
NOMESCO Finland
Total body bone isotope imaging
3.2
43.5
183
602
KDW96
NOMESCO Finland
Other operations on urethra
14.0
43.4
40
29
N02BE01
ATC
paracetamol; systemic, rectal
2.1
41.3
2744
24069
KEB00
NOMESCO Finland
Biopsy of prostate
3.7
40.3
128
352
WX402
NOMESCO Finland
General anaesthesia
1.8
39.8
708
4312
XKC03
NOMESCO Finland
Water cystometry
3.7
38.1
123
342
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
3.1
37.9
166
559
FXM00
NOMESCO Finland
Removal of extra-, para- or intracorporeal VAD
197.4
37.9
39
*
7AX01, ,
NOMESCO Finland
197.4
37.9
39
*
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.0
37.7
178
626
G04BD12
ATC
mirabegron; oral
2.0
37.2
489
2694
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
36.9
1174
8360
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.5
36.8
129
379
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
36.6
621
3717
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
13.9
35.7
33
24
742, ,
NOMESCO Finland
11.0
35.6
38
35
L04AD02
ATC
tacrolimus; systemic
5.8
35.5
65
114
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.5
35.0
224
921
WF003
NOMESCO Finland
Adjuvant radiotherapy
3.2
35.0
141
452
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
34.6
1130
8067
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
5.8
33.7
61
106
N06AX21
ATC
duloxetine; oral
2.2
33.5
287
1344
N86
ICPC
Multiple sclerosis
10.4
33.4
37
36
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
3.9
33.2
98
256
L02AE02
ATC
leuprorelin; implant, parenteral
2.1
33.1
351
1787
ZXE00
NOMESCO Finland
One hour or less
1.6
32.5
1150
8341
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.4
32.1
223
952
R4110
NOMESCO Finland
Physiotherapy
1.6
31.9
891
6095
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
9.6
29.7
35
37
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.5
28.7
190
794
A03AD01
ATC
papaverine; systemic
8.8
28.1
35
40
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
6.7
28.0
44
66
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
27.8
730
4889
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
42.9
27.7
34
8
N99.1
ICD-10 Finland
Postprocedural urethral stricture
5.0
27.7
60
123
Z3231
NOMESCO Finland
Registered nurse
1.6
27.3
903
6389
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
5.8
27.2
50
88
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
27.0
1980
16583
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
26.6
1703
13848
M03BX01
ATC
baclofen; systemic
3.7
26.5
86
240
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
4.0
26.5
74
186
N03AX12
ATC
[U] gabapentin; oral
1.8
26.4
470
2831
WX704
NOMESCO Finland
Intubation
2.1
26.3
284
1451
N03AX16
ATC
[U] pregabalin
1.6
26.1
667
4430
3A064, ,
NOMESCO Finland
6.7
25.9
41
62
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
5.8
25.8
47
82
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
2.4
25.8
186
807
SPAT1262
SPAT
Handing over of treatment supplies
1.6
25.2
678
4555
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
25.1
772
5356
J01DB01
ATC
cefalexin; oral
1.6
24.9
2433
21464
J01MA01
ATC
ofloxacin; systemic
1.9
24.5
324
1777
163
Kela drug reimbursment
Abiraterone and enzalutamide
3.2
23.5
93
295
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.9
23.5
305
1662
L04AA06
ATC
mycophenolic acid; systemic
3.4
23.4
84
251
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.3
23.2
88
272
R31
ICD-10 Finland
Unspecified haematuria
1.6
23.0
557
3635
L02BB04
ATC
enzalutamide; oral
3.2
23.0
92
294
R32
ICD-10 Finland
Unspecified urinary incontinence
3.3
23.0
89
279
127
Kela drug reimbursment
Transplant complication
3.7
22.9
74
206
J01MA12
ATC
levofloxacin; systemic
1.6
22.9
694
4782
1CX08, ,
NOMESCO Finland
5.7
22.6
42
75
Z3226
NOMESCO Finland
Physiotherapist
1.6
22.4
542
3537
G04BD11
ATC
fesoterodine; oral
2.9
22.3
109
391
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
22.3
1258
9858
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.4
22.3
153
650
KCC10
NOMESCO Finland
Cystoprostatectomy
4.4
22.2
56
130
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
22.1
389
2328
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
4.6
21.9
52
115
G04BD04
ATC
oxybutynin; oral, transdermal
2.4
21.4
147
625
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
5.0
21.3
46
94
A02BC05
ATC
esomeprazole; systemic
1.5
21.2
1103
8488
J01CA04
ATC
amoxicillin; systemic
1.5
21.2
2250
19761
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
20.8
707
4984
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.9
20.8
290
1615
WX725
NOMESCO Finland
Noninvasive ventilation
2.1
20.6
196
954
N06AX11
ATC
mirtazapine; oral
1.5
20.6
860
6332
R86.9
ICD-10 Finland
Abnormal findings in specimens from male genital organs, unspecified abnormal finding
4.7
20.5
47
101
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
20.4
810
5900
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.6
20.1
121
483
ZX108
NOMESCO Finland
Inhalation
4.5
20.1
48
107
TQW40
NOMESCO Finland
Remowal of suture of skin
2.0
19.9
220
1132
M03BX02
ATC
tizanidine; oral
1.4
19.8
1500
12313
3AC01, ,
NOMESCO Finland
4.5
19.6
48
109
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
19.5
178
853
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
3.0
19.5
87
297
J01AA02
ATC
doxycycline; systemic
1.4
19.3
2207
19445
XF622
NOMESCO Finland
Measurement of minute volume of heart
6.5
19.2
31
48
J01MA06
ATC
norfloxacin; oral
1.8
19.0
288
1647
S18
ICPC
Laceration/cut
1.4
18.9
1509
12461
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
4.2
18.9
50
121
JN4BD
NOMESCO Finland
Extensive body CT
1.7
18.7
395
2480
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
38.6
18.5
23
6
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
18.5
198
1008
M48.0
ICD-10 Finland
Spinal stenosis
1.6
18.4
433
2794
A02BC02
ATC
pantoprazole; systemic
1.4
18.4
2008
17460
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
18.2
1067
8338
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
18.1
176
865
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
33.1
18.0
23
7
KGV30
NOMESCO Finland
Implantation of prosthesis into penis
33.1
18.0
23
7
JN4AD
NOMESCO Finland
Body CT examination
1.6
17.9
466
3082
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.6
17.9
327
5168
K62.7
ICD-10 Finland
Radiation proctitis
3.7
17.8
57
158
UJF32
NOMESCO Finland
Coloscopy
1.5
17.8
843
6328
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.3
17.8
45
105
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.0
17.4
202
1058
N05CF02
ATC
zolpidem; oral
1.7
17.3
379
2399
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
4.1
17.0
46
113
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
17.0
391
2506
3A149, ,
NOMESCO Finland
50.3
17.0
20
*
N05CD07
ATC
temazepam; oral
1.6
16.7
381
2436
ZX080
NOMESCO Finland
Image guided radiotherapy
3.1
16.6
69
226
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
16.6
445
2962
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
16.2
129
586
120, ,
NOMESCO Finland
47.7
16.0
19
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
16.0
284
1699
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
16.0
474
3225
N48.3
ICD-10 Finland
Priapism
24.6
16.0
22
9
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
2.5
15.9
102
420
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
2.3
15.8
118
521
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
15.3
147
719
B01AA03
ATC
warfarin; systemic
1.4
15.3
830
6358
J01FA10
ATC
azithromycin; systemic
1.4
15.3
1201
9782
G03HA01
ATC
cyproterone; systemic
3.4
15.2
54
161
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
15.1
2443
22273
TK800
NOMESCO Finland
Hemodialysis
2.4
14.9
103
440
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
14.7
400
2665
KDV20
NOMESCO Finland
Submucous urethral injection
21.1
14.6
21
10
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
2.9
14.6
70
249
M54.5
ICD-10 Finland
Low back pain
1.4
14.6
850
6582
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
14.6
1079
8688
C05AA08
ATC
fluocortolone; rectal, topical
1.6
14.5
381
2518
N35.9
ICD-10 Finland
Urethral stricture, unspecified
2.6
14.5
83
324
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
14.2
14.5
24
17
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.2
14.4
120
555
M01AB05
ATC
diclofenac; systemic, rectal
1.3
14.4
1761
15291
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
12.6
14.4
25
20
Z2221
NOMESCO Finland
Medical doctor
1.4
14.2
711
5357
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
14.1
380
2525
OAB50, ,
SPAT
1.7
14.1
288
1788
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
14.1
857
6677
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
2.4
14.1
97
414
352
Kela drug reimbursment
Abiraterone and enzalutamide
3.0
13.9
62
212
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
13.9
868
6789
FXE00
NOMESCO Finland
Use of ECLA
30.2
13.9
18
6
N06AB10
ATC
escitalopram; oral
1.6
13.8
366
2424
ZXA10
NOMESCO Finland
Bilateral
1.5
13.8
517
3688
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
13.7
114
527
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
13.7
900
7098
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
13.7
432
2975
KA1FN
NOMESCO Finland
Isotope renography
4.2
13.7
36
87
L02BX03
ATC
abiraterone; oral
2.9
13.6
63
220
C10AA01
ATC
simvastatin; oral
1.3
13.6
1552
13293
N05BA04
ATC
oxazepam; oral
1.4
13.6
625
4637
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
13.4
311
1996
ZXD05
NOMESCO Finland
Urgent procedure
1.4
13.4
884
6973
N06AG02
ATC
moclobemide; oral
2.2
13.3
117
553
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
13.3
299
1902
C09DX04
ATC
valsartan and sacubitril; oral
2.9
13.3
63
223
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.0
13.2
134
670
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
13.1
1218
10109
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
13.0
215
1261
N30.4
ICD-10 Finland
Irradiation cystitis
6.1
12.9
22
36
L02AE03
ATC
goserelin; implant
3.0
12.9
55
184
C03DA01
ATC
spironolactone; oral
1.5
12.8
438
3066
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
5.8
12.7
23
40
A02BC01
ATC
omeprazole; systemic
1.4
12.7
763
5920
R01AD08
ATC
fluticasone; nasal
1.4
12.6
597
4446
KDK30
NOMESCO Finland
Revision of artificial urethral sphincter
32.1
12.6
16
5
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
12.5
880
6997
J01DA01
ATC
[U] cefalexin
1.3
12.5
1621
14068
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.3
12.3
89
389
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
12.3
281
1796
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
2.7
12.3
64
239
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
12.3
995
8077
ZX120
NOMESCO Finland
Intravenous
1.6
12.2
288
1854
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
12.2
294
1903
P01AB01
ATC
metronidazole; oral, rectal
1.4
12.2
851
6754
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
12.2
148
789
R01AD09
ATC
mometasone; nasal
1.3
12.2
939
7565
N06AB04
ATC
citalopram; systemic
1.5
12.1
459
3275
B01AB10
ATC
tinzaparin; parenteral
1.6
12.0
308
2024
N30.0
ICD-10 Finland
Acute cystitis
1.6
12.0
262
1656
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
2.6
11.9
67
260
TK810
NOMESCO Finland
Hemofiltration
3.6
11.9
38
106
UKD02
NOMESCO Finland
Urethroscopy
3.7
11.8
36
97
C08CA02
ATC
felodipine; oral
1.5
11.8
343
2317
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
11.8
759
5942
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
11.7
403
2819
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
11.7
1354
11528
R06AE07
ATC
cetirizine; oral
1.3
11.7
861
6877
C02KX04
ATC
macitentan; oral
65.2
11.6
13
*
0034, ,
NOMESCO Finland
65.2
11.6
13
*
3AE00, ,
NOMESCO Finland
65.2
11.6
13
*
L03
ICPC
Low back symptom/complaint
1.4
11.6
628
4780
90621, ,
NOMESCO Finland
5.3
11.5
23
44
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
10.1
11.5
22
22
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
11.4
1747
15416
C03CA01
ATC
furosemide; systemic
1.3
11.4
1145
9555
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
11.3
268
1726
A07DA03
ATC
loperamide; oral
2.1
11.3
112
555
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.4
11.3
686
5314
M02AA07
ATC
piroxicam; topical
1.3
11.3
907
7332
N02BF02
ATC
pregabalin; oral
1.8
11.3
162
911
A07EA02
ATC
hydrocortisone; rectal
2.5
11.1
70
287
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
11.1
188
1109
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
11.1
1119
9334
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.4
11.1
690
5367
WZC30
NOMESCO Finland
Teaching
1.4
11.0
512
3790
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.8
11.0
160
904
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
10.9
1006
8283
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
10.9
417
2977
J01FF01
ATC
clindamycin; systemic
1.4
10.9
729
5729
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
10.9
186
1100
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
2.0
10.9
116
591
L82
ICD-10 Finland
Seborrhoeic keratosis
1.4
10.9
497
3669
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
10.8
672
5222
C01BD01
ATC
amiodarone; systemic
1.9
10.8
130
691
A10AB01
ATC
insulin (human); parenteral
2.1
10.8
97
464
SPAT1325
SPAT
Vaccination
1.3
10.8
1002
8259
A10AA02, ,
ATC
2.1
10.7
100
485
A02BA02
ATC
ranitidine; systemic
1.4
10.7
539
4045
L03AX13
ATC
glatiramer acetate; parenteral
17.9
10.7
16
9
R1250
NOMESCO Finland
Evaluation of functional capability
2.4
10.7
74
318
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.6
10.6
243
1552
N31.8
ICD-10 Finland
Other neuromuscular dysfunction of bladder
4.1
10.6
28
68
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
10.6
705
5536
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.4
10.6
557
4213
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
3.5
10.6
36
105
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.9
10.5
134
726
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
2.5
10.5
64
259
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
10.5
511
3815
-1, ,
NOMESCO Finland
1.3
10.5
714
5626
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.9
10.4
128
685
N05BA01
ATC
diazepam; systemic, rectal
1.5
10.4
310
2104
J01CA08
ATC
pivmecillinam; oral
1.7
10.4
213
1325
Z01.2
ICD-10 Finland
Dental examination
1.3
10.4
1012
8389
L03AB08
ATC
interferon beta-1b; parenteral
32.6
10.3
13
*
474, ,
NOMESCO Finland
32.6
10.3
13
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.6
10.3
228
1445
G04BD09
ATC
trospium; oral
2.5
10.3
64
262
D01AE16
ATC
amorolfine; topical
1.5
10.2
319
2188
B01AB04
ATC
dalteparin; parenteral
1.8
10.1
152
867
WX892
NOMESCO Finland
Monitored bed care
1.6
10.1
270
1789
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.3
10.1
930
7643
AA1AD
NOMESCO Finland
CT of head and brain
1.3
10.1
959
7915
J01FA09
ATC
clarithromycin; systemic
1.4
10.1
648
5057
3054, ,
Kela drug reimbursment
2.9
10.1
47
166
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.3
10.0
71
308
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.0
10.0
102
512
G04BD
ATC
Drugs for urinary frequency and incontinence
14.6
10.0
16
11
A10AA01, ,
ATC
2.4
10.0
68
290
G47.3
ICD-10 Finland
Sleep apnoea
1.3
10.0
733
5834
R4110, ,
SPAT
1.5
10.0
337
2348
1523, ,
Kela drug reimbursment
2.8
10.0
47
167
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.4
9.9
525
3970
ZX197, ,
NOMESCO Finland
16.7
9.9
15
9
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
12.2
9.8
17
14
K02.1
ICD-10 Finland
Caries of dentine
1.3
9.8
1405
12200
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.6
9.8
219
1391
WX002
NOMESCO Finland
Sedation and analgesia
1.4
9.8
543
4136
C07AB07
ATC
bisoprolol; oral
1.3
9.8
1656
14673
L15
ICPC
Knee symptom/complaint
1.4
9.8
556
4254
5AB14, ,
NOMESCO Finland
10.6
9.8
18
17
N32.83
ICD-10 Finland
Nozzle synergy in the bladder neck
4.7
9.8
22
47
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
3.2
9.7
37
116
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.5
9.7
279
1879
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
2.9
9.7
43
148
N06AA09
ATC
amitriptyline; systemic
1.6
9.6
212
1342
A98
ICPC
Health maint/preventive medicine
1.4
9.6
2739
25966
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
5.3
9.6
19
36
G04BX04, ,
ATC
2.3
9.6
72
320
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
3.1
9.6
39
127
M79.6
ICD-10 Finland
Pain in limb
1.3
9.6
1017
8500
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
9.5
1068
8988
N04BB01
ATC
amantadine; oral
2.9
9.5
43
149
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
9.5
1302
11231
WX872
NOMESCO Finland
Intensive care
1.6
9.5
207
1307
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.0
9.5
100
508
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.2
9.5
81
380
M01AX17
ATC
nimesulide; oral
1.4
9.5
611
4763
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
9.5
1523
13389
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
9.5
566
4362
SFA20
NOMESCO Finland
Two-surface restoration
1.3
9.5
1361
11807
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.2
9.5
80
374
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.1
9.4
91
449
L03AB07
ATC
interferon beta-1a; parenteral
12.4
9.3
16
13
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.1
9.3
83
396
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
9.3
1733
15492
SFA10
NOMESCO Finland
One-surface restoration
1.3
9.3
1301
11245
Z31.5
ICD-10 Finland
Genetic counselling
2.3
9.2
67
294
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
9.2
228
1484
R50.9
ICD-10 Finland
Fever, unspecified
1.4
9.2
462
3461
L02BX02
ATC
degarelix; parenteral
2.2
9.2
74
340
WF049
NOMESCO Finland
Radiotherapy of metastasis
1.8
9.1
135
767
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
3.9
9.1
26
67
ZXA05
NOMESCO Finland
Left side
1.3
9.1
678
5398
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
9.1
819
6693
KE1CG
NOMESCO Finland
Extensive MRI of prostate
2.6
9.1
49
187
L02BB01
ATC
flutamide; oral
4.6
9.1
21
46
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
9.0
632
4985
I42.0
ICD-10 Finland
Dilated cardiomyopathy
1.8
9.0
121
667
3A422, ,
NOMESCO Finland
15.6
9.0
14
9
FBE32
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery
36.8
9.0
11
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.7
8.9
151
892
M01AH05
ATC
etoricoxib; oral
1.3
8.9
1475
12978
C07AA05
ATC
propranolol; systemic
1.4
8.9
354
2544
U07
ICPC
Urine symptom/complaint other
1.6
8.9
229
1505
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.4
8.9
59
249
Z2446
NOMESCO Finland
Social worker
1.7
8.9
157
939
D82
ICPC
Teeth/gum disease
1.3
8.9
779
6341
3400A
ICD-9 Finland
Multiple sclerosis[SCLEROSIS MULTIPLEX (DISSEMINATA)]
12.6
8.9
15
12
M01AE02
ATC
naproxen; oral, rectal
1.3
8.9
1313
11405
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
2.7
8.8
44
162
Q20.3
ICD-10 Finland
Discordant ventriculoarterial connection
50.1
8.7
10
*
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
8.7
906
7541
C10AA05
ATC
atorvastatin; oral
1.3
8.7
1448
12741
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.7
8.6
163
993
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
8.6
845
6979
N31.2
ICD-10 Finland
Flaccid neuropathic bladder, not elsewhere classified
3.0
8.6
36
120
D01AC02
ATC
miconazole; topical
1.5
8.6
238
1592
WX320
NOMESCO Finland
Spinalanesthesy
1.3
8.5
698
5627
B01AE07
ATC
dabigatran etexilate; oral
1.7
8.5
144
852
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
8.5
738
5995
D06BB04
ATC
podophyllotoxin; topical
2.3
8.5
63
280
L28
ICPC
Limited function/disability (L)
1.3
8.5
558
4360
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
2.5
8.5
52
212
KDV22
NOMESCO Finland
Transluminal endoscopic submucous urethral injection
90.3
8.4
9
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.0
8.4
90
461
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.7
8.3
134
782
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.4
8.3
477
3651
U13
ICPC
Bladder symptom/complaint other
2.1
8.3
74
355
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
8.2
201
1307
AP2
HP
Catheterization of the right side of the heart
4.2
8.2
21
50
B02AA02
ATC
tranexamic acid; systemic
1.6
8.2
170
1062
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
8.2
355
2593
I50.0
ICD-10 Finland
Congestive heart failure
1.5
8.1
301
2135
SDA03
NOMESCO Finland
Periodontal treatment
1.3
8.1
871
7263
TJF80
NOMESCO Finland
Ostomy education
2.6
8.1
45
175
ZXA00
NOMESCO Finland
Right side
1.3
8.1
723
5891
FWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of heart and major thoracic vessels
17.2
8.1
12
7
WX290
NOMESCO Finland
Other blockage of nerve
1.3
8.1
1000
8483
SPAT1153
SPAT
Removal of sutures
1.3
8.0
923
7761
N03AE01
ATC
clonazepam; systemic
1.7
8.0
136
806
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
8.0
598
4756
J01FA06
ATC
roxithromycin; oral
1.3
8.0
925
7783
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.4
8.0
300
2134
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
7.9
347
2536
U29
ICPC
Urinary symptom/complaint other
1.9
7.9
94
499
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
7.9
919
7733
M01AC06
ATC
meloxicam; systemic, rectal
1.3
7.9
810
6713
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.9
7.9
100
543
WF099
NOMESCO Finland
Other radiotherapy
3.6
7.8
25
70
A06AD11
ATC
lactulose; oral
1.3
7.8
479
3699
R42
ICD-10 Finland
Dizziness and giddiness
1.3
7.8
598
4771
6078B
ICD-9 Finland
Disorders of penis, Other specified disorders of penis[IMPOTENTIA ORGANICA]
9.4
7.8
15
16
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.5
7.7
257
1785
M01AH01
ATC
celecoxib; oral
1.4
7.7
401
3019
M01AC01
ATC
piroxicam; systemic, rectal
1.4
7.7
343
2516
D01
ICPC
Abdominal pain/cramps general
1.5
7.7
226
1531
L01
ICPC
Neck symptom/complaint
1.4
7.7
296
2116
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.3
7.6
511
4000
Y28
ICPC
Limited function/disability (Y)
3.6
7.6
24
67
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
3.6
7.6
24
67
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.5
7.6
214
1438
A07EC02
ATC
mesalazine; oral, rectal
1.7
7.5
125
736
J01DA09
ATC
[U] cefadroxil
1.3
7.5
604
4845
R86
ICD-10 Finland
Abnormal findings in specimens from male genital organs
6.2
7.5
19
31
I50.1
ICD-10 Finland
Left ventricular failure
1.5
7.5
215
1449
R03AC02
ATC
salbutamol; inhalant
1.2
7.5
1270
11135
N31.1
ICD-10 Finland
Reflex neuropathic bladder, not elsewhere classified
3.0
7.5
31
103
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.6
7.4
41
159
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.6
7.4
165
1050
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.1
7.4
67
324
KH1AD
NOMESCO Finland
CT of urinary organs
1.7
7.3
127
757
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
7.3
577
4616
D01BA02
ATC
terbinafine; oral
1.3
7.3
789
6569
M01AX05
ATC
glucosamine; oral
1.3
7.3
463
3591
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
1.9
7.3
83
435
C02KX01
ATC
bosentan; oral
+∞
7.3
7
*
FM2CE, ,
NOMESCO Finland
9.4
7.3
14
15
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.2
7.3
1011
8668
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
7.3
688
5639
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
3.8
7.2
21
55
N02BF01
ATC
gabapentin; oral
1.5
7.2
226
1550
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
3.4
7.2
25
74
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.3
7.2
619
5008
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
7.2
593
4772
KCH42
NOMESCO Finland
Transurethral incision or resection of bladder neck
3.7
7.2
22
60
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
4.5
7.2
17
38
164
Kela drug reimbursment
Fingolimod
30.1
7.1
9
*
SPAT1263
SPAT
Sampling
1.2
7.1
1057
9122
H02AB06
ATC
prednisolone; systemic
1.2
7.1
1308
11547
TFP20
NOMESCO Finland
Cardiodefibrillation
1.4
7.1
283
2036
L17
ICPC
Foot/toe symptom/complaint
1.3
7.0
761
6334
KE003
NOMESCO Finland
Adjuvant radiotherapy of prostata and seminal vesicles
10.0
7.0
13
13
I50.9
ICD-10 Finland
Heart failure, unspecified
1.3
6.9
559
4483
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
6.9
511
4049
TKC22
NOMESCO Finland
Catheterisation instruction
1.7
6.9
112
656
A03CA02
ATC
clidinium and psycholeptics; oral
1.6
6.9
140
871
U01
ICPC
Dysuria/painful urination
1.8
6.9
93
516
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
3.1
6.9
28
92
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.0
6.9
73
374
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
2.5
6.8
41
166
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
3.5
6.8
23
67
N02AA05
ATC
oxycodone; systemic
1.3
6.8
609
4952
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
6.8
321
2378
SPAT1336
SPAT
Request for examination
1.8
6.8
93
519
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
6.8
418
3230
L04AA27
ATC
[U] fingolimod
40.1
6.8
8
*
N07BC02
ATC
methadone; systemic
4.3
6.7
17
40
Z93.5
ICD-10 Finland
Cystostomy status
3.6
6.7
21
58
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.5
6.7
233
1632
N06AB03
ATC
fluoxetine; oral
1.5
6.6
226
1579
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
6.6
183
1225
J02AC01
ATC
fluconazole; systemic
1.3
6.6
465
3661
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
6.6
265
1909
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
6.6
427
3324
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.5
6.6
173
1146
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
6.5
822
6953
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
3.3
6.5
24
74
R33
ICD-10 Finland
Retention of urine
1.3
6.5
397
3059
N04BC05
ATC
pramipexole; oral
1.5
6.5
185
1244
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
1.7
6.5
110
653
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
1.8
6.5
90
504
Z51.0
ICD-10 Finland
Radiotherapy session
2.3
6.5
45
195
A41.9
ICD-10 Finland
Sepsis, unspecified
1.7
6.5
125
768
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
6.5
462
3643
TKD00
NOMESCO Finland
Dilatation of urethra
2.7
6.5
34
129
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
6.5
248
1771
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
6.5
438
3429
L86
ICPC
Back syndrome with radiating pain
1.6
6.5
134
839
R01AD12
ATC
fluticasone furoate; nasal
1.3
6.5
526
4223
R13
ICD-10 Finland
Dysphagia
1.5
6.4
203
1396
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.8
6.4
89
498
KGV40
NOMESCO Finland
Revision of penile prosthesis
70.0
6.4
7
*
AM4
HP
VAD (use of the left and / or right side mechanical support (other than IABP)
70.0
6.4
7
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
6.4
714
5955
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.8
6.4
90
506
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.1
6.4
57
274
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
6.4
210
1457
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.2
6.4
51
235
R5110, ,
SPAT
1.5
6.3
223
1567
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.6
6.3
145
930
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
6.3
631
5196
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
6.3
539
4353
KDK40
NOMESCO Finland
Removal of artificial urethral sphincter
11.0
6.3
11
10
G82.1
ICD-10 Finland
Spastic paraplegia
9.3
6.3
12
13
N06BA07
ATC
modafinil; oral
9.3
6.3
12
13
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
3.5
6.3
21
61
G04BXXX, ,
ATC
18.0
6.3
9
5
Q20.48
ICD-10 Finland
Single ventricle
+∞
6.3
6
*
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
6.2
875
7486
353
Kela drug reimbursment
Cladribine and fingolimod
26.7
6.2
8
*
WYA10
NOMESCO Finland
Emergency care or similar visit
1.6
6.2
128
800
R5140
NOMESCO Finland
Monitoring the use of the aid
1.4
6.2
346
2631
N05CD05
ATC
triazolam; oral, sublingual
2.4
6.2
39
162
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
6.2
120
739
A10AB04
ATC
insulin lispro; parenteral
1.9
6.2
74
396
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.2
6.2
749
6306
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.3
6.2
43
187
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.9
6.2
70
368
AS7
HP
Arrhythmia pacemaker insertion VVI (R) S
4.0
6.2
17
43
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.4
6.1
41
175
I47.2
ICD-10 Finland
Ventricular tachycardia
1.8
6.1
84
470
SPAT1301
SPAT
No procedures
1.2
6.1
835
7123
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
2.0
6.1
64
328
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
2.2
6.1
49
227
WX720
NOMESCO Finland
Own respiration
1.6
6.0
137
878
R4190
NOMESCO Finland
Nutritional therapy
1.7
6.0
97
569
J01XE01
ATC
nitrofurantoin; oral
3.5
6.0
20
58
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
2229
17767
1.86
53.45
6.1
4.8
29.55
858.13
e6/l
1.42
56
321
2467
21067
1.78
38.17
14.1
9.3
79.38
82.98
u/l
3.46
2373
20094
688
4254
1.79
36.38
2.5
2.3
12.60
13.05
nmol/l
0.56
596
3743
65
113
5.85
35.84
1.4
1.2
—
—
—
0
0
1686
13224
1.59
34.80
3.9
3.2
—
—
estimate
—
0
0
1072
7618
1.62
33.13
3.2
3.0
2.32
2.83
e6/l
2.75
981
6967
2477
21481
1.71
32.60
10.4
6.0
4.22
3.35
ug/l
0.87
1968
19437
1406
10760
1.55
30.97
4.5
3.9
144.83
114.61
e6/l
0.14
1141
8514
108
338
3.27
27.90
1.7
1.3
3.72
5.94
u/ml
0.77
64
162
103
317
3.32
27.34
1.7
1.1
—
—
—
0
0
1451
11436
1.50
26.34
5.4
4.5
70.34
102.75
e6/l
1.43
1154
8710
148
573
2.66
26.13
12.6
6.3
10.38
11.98
mg/l
4.93
142
527
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
36
47
7.74
25.93
1.9
1.4
76.74
78.95
%
0.11
31
20
106
351
3.09
24.95
1.7
1.3
4.00
3.61
u/ml
0.09
49
127
2080
17772
1.50
24.41
10.1
6.0
6.89
7.01
mmol/l
1.69
2004
17105
1203
9241
1.49
24.14
4.3
3.8
0.33
0.45
e6/l
1.87
944
7049
1881
15877
1.46
22.52
27.2
20.5
1.40
1.38
inr
0.75
1646
13593
34
50
6.86
22.07
1.3
1.2
22.34
163.22
ng/l
1.48
28
35
1831
15427
1.44
21.78
12.8
7.4
12.51
13.66
umol/l
4.09
1774
14838
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
271
1464
1.93
21.36
11.1
2.9
0.29
0.32
iu/ml
1.33
167
778
1633
13563
1.42
20.43
6.5
6.0
34.52
34.53
g/l
0.01
1541
12712
1683
14070
1.42
20.20
4.3
3.8
0.00
0.00
estimate
0.80
419
3107
1630
13559
1.42
20.07
12.9
7.9
1.20
1.20
mmol/l
0.30
1519
12569
1702
14309
1.41
19.47
4.3
3.9
0.02
0.12
estimate
0.50
404
2839
470
3056
1.63
19.47
8.1
3.1
294.42
236.16
ng/l
1.23
439
2830
78
252
3.15
19.20
2.5
2.3
21.82
31.94
iu/ml
0.53
12
42
1690
14248
1.40
18.68
4.3
3.8
6.35
2.19
estimate
0.43
432
3129
198
1013
2.02
18.23
6.1
3.6
4.49
4.39
pmol/l
0.73
181
897
1768
15056
1.40
18.20
13.1
8.6
1.20
1.20
mmol/l
0.23
1526
13030
1173
9321
1.41
18.17
4.6
3.8
2.32
2.33
mmol/l
1.64
1058
8409
371
2315
1.68
17.96
24.3
10.7
16.32
16.01
%
1.44
349
2237
185
965
1.97
16.13
12.3
2.4
3.67
3.63
g/l
0.14
180
920
113
488
2.36
15.92
1.7
1.5
129.82
152.13
au/ml
0.98
37
150
1120
9011
1.38
15.44
4.7
3.5
35.59
40.86
u/l
1.11
1071
8476
539
3813
1.50
15.10
18.8
9.0
121.97
121.75
g/l
0.09
517
3729
2685
24931
1.51
15.00
29.4
21.1
30.98
30.48
mg/l
0.31
2374
21437
937
7361
1.39
14.80
3.5
2.8
—
—
—
0
0
109
479
2.32
14.78
1.5
1.3
254.30
280.25
u/ml
0.46
89
284
621
4544
1.46
14.62
17.2
8.1
0.55
0.79
mmol/l
0.82
488
3703
479
3330
1.52
14.55
3.9
3.9
—
—
—
0
0
2212
19893
1.37
14.31
37.8
25.9
13.91
13.90
%
0.11
2186
19639
576
4190
1.46
13.92
18.0
8.3
95.95
95.22
%
2.76
548
4050
621
4591
1.44
13.75
17.3
8.2
12.03
11.85
kpa
0.43
587
4426
621
4591
1.44
13.75
17.3
8.2
5.01
5.06
kpa
0.73
587
4425
911
7201
1.37
13.64
4.0
3.5
0.02
0.03
estimate
0.22
344
2378
1140
9339
1.35
13.52
3.3
2.9
60.25
69.40
u/l
0.53
1063
8718
151
782
1.98
13.47
5.2
7.6
11.37
11.58
mmol/l
0.30
131
699
151
782
1.98
13.47
5.2
7.6
105.27
105.06
mmol/l
0.23
131
699
1042
8425
1.35
13.46
3.3
2.4
2.84
2.87
mg/l
0.13
918
7275
1018
8203
1.36
13.44
4.5
4.0
0.00
0.00
estimate
0.00
384
2671
119
567
2.14
13.30
1.7
1.5
—
17.96
—
0
13
822
6428
1.38
13.06
6.7
4.5
1200.25
637.58
ng/l
0.49
733
5721
710
5463
1.39
12.35
4.3
3.7
0.77
0.65
e6/l
0.48
387
2984
110
529
2.12
12.03
1.5
1.3
—
125.48
—
0
5
2763
26038
1.49
12.01
37.5
25.9
139.50
139.61
mmol/l
1.47
2719
25575
759
5930
1.37
11.96
4.3
2.9
12.80
12.48
umol/l
0.53
710
5536
1780
15696
1.31
11.96
11.7
9.8
4.52
4.48
e9/l
0.23
1535
13482
45
140
3.25
11.90
10.5
30.9
155.11
118.26
ug/l
1.04
18
119
683
5258
1.38
11.77
4.5
2.9
22.53
22.83
%
0.22
640
4908
2764
26074
1.48
11.70
37.9
26.2
4.04
4.04
mmol/l
0.19
2716
25581
930
7554
1.33
11.20
8.0
4.9
79.29
80.00
%
0.36
918
7436
1241
10508
1.30
10.98
4.4
3.9
0.03
0.02
estimate
0.46
364
2610
1533
13359
1.29
10.79
9.2
6.8
23.95
25.19
%
4.23
1454
12614
70
292
2.43
10.76
1.2
1.2
167.40
156.06
miu/ml
0.09
15
69
346
2392
1.50
10.65
25.8
10.1
24.13
24.08
mmol/l
0.12
337
2343
713
5617
1.35
10.46
4.4
2.9
2.22
2.20
g/l
0.41
670
5209
1146
9669
1.29
10.21
2.9
2.4
319.39
258.95
u/l
0.65
1090
9134
1500
13101
1.28
10.11
9.0
6.6
60.12
58.97
%
3.14
1440
12486
339
2367
1.48
9.93
1.8
1.7
—
—
—
0
0
755
6059
1.32
9.66
2.2
2.0
—
—
—
0
0
177
1070
1.69
9.62
1.7
1.8
—
—
—
0
0
2108
19264
1.28
9.55
5.3
4.4
12.99
13.47
mm/h
0.63
1963
17895
501
3788
1.38
9.45
29.2
7.8
11.43
11.31
mmol/l
0.13
484
3622
1317
11385
1.27
9.43
4.2
3.2
176.66
198.92
ug/l
1.56
1217
10475
1405
12277
1.26
9.07
2.4
2.3
—
—
—
0
0
701
5649
1.31
8.57
10.1
3.6
0.82
0.81
mmol/l
0.89
666
5354
598
4718
1.33
8.50
11.0
7.2
1.05
1.04
mmol/l
0.50
561
4459
1371
12007
1.25
8.48
17.7
13.4
0.00
0.00
e9/l
0.82
1128
9775
1617
14433
1.25
8.41
8.7
6.4
1.70
1.87
e9/l
4.24
1429
12528
2775
26477
1.39
8.39
39.1
28.1
95.26
92.41
umol/l
2.14
2751
26152
1631
14596
1.24
8.20
9.1
6.5
0.20
0.21
e9/l
1.28
1429
12568
575
4535
1.33
8.16
2.2
1.9
—
—
—
0
0
537
4204
1.33
8.01
2.2
2.0
—
—
—
0
0
1200
10401
1.25
8.00
2.1
2.0
1.26
1.33
mmol/l
2.73
948
8546
32
104
3.10
7.97
6.2
7.5
5.03
5.34
kpa
0.43
32
104
125
726
1.75
7.90
10.0
5.9
1420.36
3568.06
iu/ml
0.45
22
120
2542
24000
1.30
7.78
29.2
21.0
73.44
74.49
ml/min/173m2
1.88
2406
22523
576
4595
1.31
7.49
15.0
4.5
250.59
242.90
u/l
0.52
548
4352
2373
22268
1.26
7.26
5.0
4.4
1.99
2.06
mu/l
1.93
2134
20093
2728
26067
1.34
7.24
19.0
13.6
27.01
28.10
u/l
1.50
2650
25201
686
5628
1.28
7.17
9.9
2.1
31.93
30.25
s
6.51
674
5491
443
3425
1.34
7.15
22.7
8.2
1.35
1.40
mmol/l
0.60
432
3350
2777
26640
1.35
6.90
43.1
31.3
4.46
4.49
e12/l
1.31
2715
25922
2777
26640
1.35
6.90
43.0
31.2
91.88
91.94
fl
0.26
2742
26299
2777
26641
1.35
6.89
46.3
32.0
40.45
40.54
%
0.38
2744
26284
2777
26642
1.35
6.88
43.5
31.6
135.37
136.41
g/l
2.65
2745
26310
2777
26643
1.35
6.87
43.2
31.3
7.02
7.09
e9/l
0.67
2719
25917
163
1055
1.57
6.83
1.3
1.3
—
—
—
0
0
2776
26637
1.35
6.82
43.2
31.3
227.55
227.49
e9/l
0.01
2724
26010
409
3148
1.34
6.80
2.8
2.3
0.20
0.20
g/l
0.80
379
2906
708
5867
1.27
6.77
4.1
3.5
0.74
0.88
e6/l
0.79
386
3389
327
2434
1.38
6.72
2.6
2.5
170.41
173.59
ug/g
0.05
258
1982
122
738
1.68
6.71
1.6
1.6
—
—
—
0
0
1888
17351
1.22
6.69
7.3
4.9
17.75
22.32
%
31.74
902
9351
1367
12176
1.22
6.65
5.2
4.5
57.11
83.77
ng/l
0.88
1156
9930
1493
13415
1.21
6.64
2.3
2.3
93.30
91.04
pmol/l
1.15
882
7936
1059
9199
1.23
6.59
1.9
1.8
18.53
18.89
nmol/l
0.38
908
7868
1886
17345
1.22
6.58
3.9
3.3
15.09
14.99
pmol/l
0.92
1692
15553
395
3041
1.34
6.55
3.4
2.8
0.56
0.45
e6/l
0.35
384
2958
209
1445
1.48
6.46
2.4
2.2
0.03
0.71
estimate
0.50
60
373
246
1756
1.43
6.44
4.8
5.6
1.65
1.64
%
0.12
224
1661
13
16
8.15
6.32
5.9
6.6
104.23
105.69
g/l
0.13
13
16
446
3512
1.31
6.32
3.0
3.1
8.93
10.76
umol/l
1.33
403
3187
1771
16226
1.21
6.28
3.8
3.6
59.27
62.97
u/l
0.79
1645
15038
356
2718
1.35
6.23
2.9
2.7
33.76
40.76
u/l
1.35
308
2318
85
476
1.81
6.15
1.4
1.6
—
—
—
0
0
149
976
1.55
5.96
1.9
1.9
231.75
201.66
pmol/l
1.96
139
915
681
5702
1.25
5.86
10.4
1.7
1.73
1.64
mg/l
0.19
553
4550
422
3331
1.31
5.86
2.8
2.5
21.03
8.15
ug/l
4.76
386
2960
745
6303
1.24
5.83
4.3
4.1
1.02
1.02
kg/l
0.48
572
4386
143
939
1.55
5.67
1.5
1.7
—
—
—
0
0
413
3268
1.30
5.63
2.3
2.7
65.06
65.75
g/l
0.99
382
2984
317
2417
1.35
5.61
7.5
7.3
24.38
24.33
mmol/l
0.09
294
2321
107
659
1.65
5.55
1.3
1.3
—
—
—
0
0
1198
10675
1.20
5.47
2.5
2.3
80.50
76.27
nmol/l
5.29
1064
9415
37
161
2.31
5.35
1.3
1.3
33.10
27.23
u/l
0.30
31
135
2543
24310
1.24
5.18
6.2
5.6
4.12
4.18
mmol/l
2.14
2325
22471
246
1827
1.38
5.16
2.1
1.9
2.38
2.66
ug/l
0.15
219
1607
146
985
1.51
5.14
6.2
3.9
1.79
1.79
mg/l
0.02
124
886
2524
24133
1.23
5.00
6.0
5.5
1.30
1.30
mmol/l
0.19
2294
22116
43
207
2.09
4.90
2.0
1.3
85.56
85.69
—
7
13
1222
11000
1.18
4.79
10.3
3.5
1789.55
1840.77
ng/l
0.15
1080
9748
37
170
2.19
4.74
1.3
1.3
114.45
103.16
u/l
0.22
31
142
301
2337
1.32
4.72
5.3
4.1
1.05
1.74
mmol/l
3.13
219
1677
102
649
1.59
4.70
1.4
1.8
—
—
—
0
0
2537
24311
1.22
4.69
6.0
5.9
6.18
6.22
mmol/l
0.75
2279
22006
2585
24827
1.23
4.62
7.0
6.5
2.36
2.40
mmol/l
1.95
2365
22829
219
1627
1.37
4.61
5.1
5.8
0.90
0.85
%
1.32
197
1539
133
904
1.49
4.56
1.8
1.6
—
—
—
0
0
137
939
1.48
4.51
1.5
1.7
—
—
—
0
0
113
745
1.54
4.48
5.2
5.2
1.86
2.45
mmol/l
2.07
73
509
135
926
1.48
4.43
2.6
2.7
28.45
34.88
umol/l
3.21
122
830
342
2726
1.29
4.42
5.6
4.3
5.01
5.10
kpa
1.60
330
2596
2432
23261
1.20
4.32
5.1
4.7
1.27
1.30
mmol/l
1.09
2174
21117
37
178
2.09
4.26
1.2
1.2
—
—
—
0
0
69
417
1.67
3.95
1.8
1.7
4.81
3.76
iu/l
0.22
20
137
87
558
1.57
3.93
4.8
3.1
1168.50
2463.74
u/ml
—
8
50
78
491
1.60
3.82
1.4
1.6
—
—
—
0
0
286
2272
1.28
3.81
2.0
1.8
—
—
—
0
0
299
2392
1.28
3.77
4.6
4.7
1.21
1.21
mmol/l
0.10
259
2103
21
84
2.51
3.71
6.0
7.9
11.45
10.24
%
0.97
21
84
464
3908
1.22
3.69
7.0
4.2
5.77
5.80
kpa
0.29
451
3802
51
289
1.78
3.69
6.8
3.7
18.11
11.61
index
1.30
36
174
10
21
4.77
3.55
1.5
1.2
—
—
—
0
0
250
1975
1.29
3.50
1.9
1.7
1.51
1.54
g/l
0.18
211
1712
49
280
1.76
3.47
1.3
1.2
93.89
66.04
u/l
0.73
41
248
113
789
1.45
3.46
1.1
1.1
—
—
—
0
0
68
427
1.61
3.40
1.3
1.3
—
—
—
0
0
451
3821
1.21
3.38
7.1
4.2
1.38
1.61
mmol/l
0.75
392
3278
87
580
1.51
3.36
2.9
1.6
9.57
4.55
mg/l
1.83
73
426
1373
12714
1.14
3.32
4.1
3.5
0.75
0.80
ug/l
1.01
865
9076
2493
24087
1.17
3.09
7.8
7.7
40.47
40.88
mmol/mol
1.49
2296
22293
109
776
1.42
3.05
1.3
1.4
—
—
—
0
0
8
16
5.01
3.05
5.4
2.1
—
—
—
0
0
110
792
1.40
2.90
1.5
1.5
—
—
—
0
0
32
172
1.87
2.81
3.4
2.3
143.47
148.07
ng/l
0.05
32
172
9
23
3.92
2.77
1.2
1.4
—
—
—
0
0
944
8621
1.14
2.70
3.3
3.3
381.07
375.07
umol/l
0.91
814
7494
36
204
1.77
2.69
1.8
2.3
—
—
—
0
0
258
2118
1.24
2.67
5.6
4.9
118.85
109.94
ng/l
0.59
220
1848
659
5880
1.15
2.65
1.9
1.8
1136.67
1133.31
nmol/l
0.03
498
4492
183
1444
1.28
2.65
6.7
4.5
24.24
24.57
mmol/l
0.93
170
1313
117
866
1.36
2.65
4.8
3.6
3.75
1.86
index
2.30
61
480
7
15
4.67
2.59
3.0
1.1
—
—
—
0
0
28
149
1.89
2.56
1.1
1.1
—
—
—
0
0
54
348
1.56
2.51
1.2
1.9
—
—
—
0
0
8
21
3.82
2.46
1.7
1.8
—
—
—
0
0
702
6323
1.14
2.46
2.0
1.8
20175855.89
28048487.21
pmol/l
0.21
570
5241
80
566
1.42
2.39
1.9
2.1
1.95
1.72
mmol/l
0.95
80
549
94
687
1.38
2.34
1.4
1.5
—
—
—
0
0
28
154
1.83
2.33
1.1
1.1
—
—
—
0
0
28
154
1.83
2.33
1.1
1.1
—
—
—
0
0
27
148
1.83
2.28
1.1
1.1
—
—
—
0
0
19
92
2.07
2.27
1.1
1.1
—
—
—
0
0
94
692
1.37
2.25
1.4
1.3
—
—
—
0
0
94
692
1.37
2.25
1.4
1.3
—
—
—
0
0
10
35
2.86
2.20
1.0
2.0
—
—
—
0
0
59
401
1.48
2.19
3.4
3.6
—
—
—
0
0
29
165
1.76
2.19
1.1
1.1
—
—
—
0
0
428
3760
1.16
2.13
3.4
2.6
68.72
67.54
e9/l
0.29
306
2836
132
1032
1.29
2.11
2.3
2.5
0.00
0.00
g/l
-0.00
127
961
222
1844
1.22
2.10
1.5
1.5
—
—
—
0
0
117
902
1.31
2.08
2.7
2.5
127.02
129.17
g/l
0.34
88
702
54
365
1.49
2.07
1.2
1.9
—
—
—
0
0
17
82
2.08
2.06
1.2
1.2
—
—
—
0
0
111
852
1.31
2.04
1.2
1.2
57.18
108.99
u/ml
1.25
31
252
24
132
1.82
2.03
1.2
1.3
—
—
—
0
0
61
426
1.44
2.00
1.8
2.0
89.58
89.15
%
0.26
61
420
24
133
1.81
1.99
1.2
1.3
—
—
—
0
0
78
570
1.38
1.99
1.2
1.2
—
—
—
0
0
46
304
1.52
1.98
1.6
1.6
—
—
—
0
0
492
4392
1.14
1.97
1.3
1.2
0.98
2.17
u/ml
4.58
111
1107
7
21
3.34
1.96
2.7
1.3
44.53
13.14
pmol/l
—
7
16
627
5688
1.13
1.95
3.5
3.4
2.45
2.45
mmol/l
0.02
549
5063
368
3223
1.16
1.93
5.9
3.5
4.69
4.51
kpa
0.52
350
3129
181
1488
1.23
1.92
2.3
2.5
2.94
2.90
g/l
0.21
166
1349
32
196
1.64
1.89
1.9
2.6
612.83
555.06
e6/l
0.13
23
164
12
52
2.31
1.87
1.0
1.3
—
—
—
0
0
77
569
1.36
1.85
1.2
1.2
—
—
—
0
0
26
152
1.72
1.83
2.9
2.2
—
—
—
0
0
5
12
4.17
1.82
1.6
1.6
7.21
4.33
mg/l
—
5
6
29
176
1.65
1.79
2.8
2.1
—
—
—
0
0
13
60
2.17
1.77
12.5
12.5
5.52
5.46
mmol/l
0.04
13
60
85
643
1.33
1.77
1.6
1.6
—
—
—
0
0
33
208
1.59
1.76
1.2
1.5
11.53
12.50
iu/l
0.18
28
160
68
497
1.38
1.76
1.2
1.4
6.43
6.27
mmol/l
0.17
56
463
87
661
1.33
1.76
2.3
2.0
14.87
25.01
ug/l
4.20
87
646
167
1376
1.23
1.76
2.4
2.5
1.12
1.11
g/l
0.01
148
1176
6
18
3.34
1.74
1.2
1.0
6.37
6.29
mmol/l
—
6
18
181
1505
1.21
1.74
2.9
2.7
—
—
—
0
0
21
119
1.77
1.66
3.3
2.5
4.76
4.83
kpa
0.12
21
119
21
119
1.77
1.66
3.3
2.5
8.49
9.96
kpa
2.31
21
119
24
142
1.70
1.64
1.2
1.3
—
—
—
0
0
6
20
3.00
1.58
1.2
1.1
—
—
—
0
0
31
199
1.56
1.56
2.0
2.7
280.46
241.72
e6/l
0.29
24
177
94
737
1.28
1.55
2.1
1.3
32.39
45.35
u/l
0.76
80
644
189
1599
1.19
1.55
2.4
2.4
3.72
3.75
g/l
0.09
173
1458
135
1108
1.23
1.51
2.2
2.4
0.00
0.00
g/l
0.50
127
964
189
1603
1.19
1.51
2.4
2.4
4.06
4.10
g/l
0.39
175
1465
6
21
2.86
1.50
1.2
1.0
—
—
—
0
0
189
1604
1.19
1.50
2.4
2.4
7.20
7.33
g/l
0.52
175
1462
0
45
0.00
1.49
0.0
2.4
—
182.26
—
0
7
62
463
1.35
1.45
26.3
22.0
6.94
7.32
mmol/l
0.49
56
394
90
709
1.28
1.45
1.2
1.2
—
—
—
0
0
372
3333
1.13
1.44
1.3
1.2
22.97
11.79
u/ml
0.35
133
1165
15
80
1.88
1.44
1.1
1.1
—
—
—
0
0
258
2258
1.16
1.42
1.3
1.3
—
—
—
0
0
87
685
1.28
1.41
1.5
1.5
—
—
—
0
0
163
1377
1.19
1.38
2.4
2.5
10.66
10.37
g/l
0.34
145
1224
76
591
1.29
1.36
1.6
1.5
—
—
—
0
0
38
266
1.43
1.32
1.5
1.4
140.52
200.71
pmol/l
0.91
38
266
34
233
1.46
1.31
1.6
1.6
—
—
—
0
0
36
250
1.45
1.30
1.3
1.4
—
—
—
0
0
105
856
1.23
1.29
1.4
1.5
298.31
243.69
ug/g
1.78
60
562
11
206
0.53
1.29
1.1
1.2
—
—
—
0
0
138
1157
1.20
1.29
2.3
2.4
0.00
0.04
g/l
2.18
131
1033
8
34
2.36
1.29
1.3
1.1
—
—
—
0
0
41
293
1.40
1.28
1.3
1.4
22.80
23.97
%
0.07
23
183
93
749
1.25
1.28
2.6
3.1
0.73
0.84
nmol/l
1.35
63
580
167
1429
1.18
1.25
1.3
1.3
54.27
67.73
au/ml
0.32
12
104
393
3569
1.12
1.24
1.3
1.3
37.96
38.46
iu/ml
0.02
118
979
77
611
1.27
1.21
1.4
1.5
838.28
3535.25
e6/l
1.19
54
435
245
2166
1.14
1.20
1.5
1.4
—
—
—
0
0
107
887
1.21
1.15
1.4
1.5
4.81
7.23
iu/ml
0.52
21
204
18
110
1.64
1.15
1.2
1.2
6.18
6.37
mmol/l
0.30
18
104
18
110
1.64
1.15
1.0
1.8
—
20.96
—
0
20
8
39
2.05
1.15
1.3
1.2
—
—
—
0
0
25
166
1.51
1.14
2.4
2.7
212.68
208.21
u/l
0.07
25
161
16
95
1.69
1.13
1.0
1.1
1251.06
1501.44
miu/ml
0.55
16
95
69
547
1.27
1.11
1.3
1.5
31275.37
67333.77
e6/l
1.07
35
335
23
151
1.53
1.11
1.7
1.7
4.81
7.15
u/l
0.44
17
126
23
151
1.53
1.11
1.8
1.5
2.12
3.62
u/field
0.44
17
106
53
406
1.31
1.11
1.2
1.3
11.51
13.11
u/l
0.39
43
379
35
251
1.40
1.10
2.2
2.1
7.26
7.86
mmol/l
0.94
35
251
269
2410
1.13
1.09
6.3
3.6
126.39
128.69
g/l
0.80
258
2347
95
784
1.22
1.08
1.6
1.6
2.76
13.06
iu/ml
0.68
22
168
384
3514
1.11
1.07
5.1
4.6
7.72
28.03
ug/l
3.56
317
2995
6
125
0.48
1.04
1.0
1.1
—
—
—
0
0
36
263
1.37
1.03
1.1
1.3
—
—
—
0
0
2025
19768
1.07
1.02
39.9
27.1
332.85
333.36
g/l
1.73
2007
19644
36
264
1.37
1.01
1.1
1.1
23.20
32.33
u/ml
—
5
6
81
663
1.23
1.01
1.4
1.4
8.27
6.83
u/l
0.82
66
530
78
636
1.23
1.01
3.1
3.7
27.60
34.05
mg/l
1.14
52
453
178
1564
1.15
0.99
2.4
2.4
24.36
17.58
au/ml
0.38
11
119
138
1190
1.17
0.99
2.3
1.7
36.60
37.28
u/l
0.12
112
1016
47
361
1.31
0.99
1.4
1.5
60.73
64.00
%
0.21
30
231
35
257
1.37
0.98
1.6
1.5
—
—
—
0
0
23
156
1.48
0.98
1.0
1.2
—
—
—
0
0
137
1581
0.86
0.97
4.2
3.5
1.02
1.02
ratio
1.31
123
1454
7
36
1.95
0.97
1.1
1.1
—
—
—
0
0
21
307
0.68
0.96
1.9
2.2
856.11
657.29
ml
—
9
185
452
4195
1.09
0.95
1.5
1.6
2.62
2.90
g/l
2.12
273
2569
13
77
1.69
0.95
1.3
1.2
32.00
31.27
u/l
—
6
60
66
534
1.24
0.93
1.1
1.1
—
—
—
0
0
10
55
1.82
0.92
1.2
1.3
—
—
—
0
0
320
3490
0.91
0.91
8.8
8.5
—
—
—
0
0
6
28
2.14
0.91
1.3
1.1
—
—
—
0
0
6
29
2.07
0.89
1.2
1.3
—
—
—
0
0
5
102
0.49
0.89
1.0
1.1
—
—
—
0
0
8
42
1.91
0.88
1.1
1.1
—
—
—
0
0
8
44
1.82
0.85
1.1
1.2
—
—
—
0
0
8
44
1.82
0.85
1.0
1.1
—
—
—
0
0
149
1313
1.14
0.83
1.9
1.9
—
—
—
0
0
191
1712
1.12
0.82
1.7
2.1
1.39
1.35
g/l
0.06
172
1568
25
180
1.39
0.82
3.6
1.9
—
—
—
0
0
63
517
1.22
0.81
1.2
1.4
322.85
349.13
u/l
0.14
56
490
70
581
1.21
0.81
1.3
1.3
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
6
33
1.82
0.79
2.8
2.0
—
—
—
0
0
6
33
1.82
0.79
1.0
1.2
—
—
—
0
0
8
48
1.67
0.78
1.0
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
131
1.45
0.78
1.3
1.1
—
—
—
0
0
24
174
1.38
0.76
2.1
1.8
—
—
—
0
0
30
227
1.32
0.74
1.7
1.6
—
—
—
0
0
238
2185
1.10
0.68
2.7
2.8
10.45
10.76
g/l
0.58
213
2023
9
59
1.53
0.68
1.1
1.2
—
—
—
0
0
15
102
1.47
0.67
1.3
1.2
1.35
1.45
mmol/l
—
7
71
53
439
1.21
0.66
3.6
4.1
58.07
57.93
%
0.02
47
369
21
281
0.75
0.64
1.1
1.2
2.17
1.98
u/ml
0.03
14
162
268
2484
1.09
0.64
3.1
3.0
56.88
61.57
ml/min/173m2
1.34
122
1075
255
2359
1.09
0.63
2.4
2.6
364.23
376.96
nmol/l
0.46
240
2192
41
333
1.23
0.62
2.2
1.7
5.09
4.36
mmol/24h
0.61
36
293
11
71
1.55
0.62
1.2
1.1
—
—
—
0
0
5
30
1.67
0.61
1.2
1.0
—
—
—
0
0
26
200
1.30
0.60
1.9
1.7
97.92
100.65
umol/l
0.14
26
200
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
82
715
1.15
0.59
1.4
1.5
31.32
31.58
g/l
0.06
71
637
9
60
1.50
0.54
1.0
1.1
—
—
—
0
0
145
1319
1.10
0.54
3.6
3.8
82.63
4105.70
u/ml
1.24
129
1154
155
1416
1.10
0.53
2.0
2.1
—
—
—
0
0
10
66
1.52
0.52
1.2
1.1
—
—
—
0
0
16
117
1.37
0.52
1.4
1.5
—
1595556.13
iu/ml
—
0
8
144
1313
1.10
0.52
1.3
1.3
232.45
316.24
u/ml
0.82
130
1207
12
83
1.45
0.51
2.4
3.0
8.92
434.77
ug/l
0.66
12
83
35
287
1.22
0.51
1.3
1.3
—
—
—
0
0
1158
11289
1.04
0.51
3.7
3.7
8.20
8.20
mmol/l
0.00
952
9447
6
41
1.46
0.50
1.5
1.5
53.33
46.24
umol/l
—
6
41
16
118
1.36
0.50
1.2
1.1
90.94
226.36
iu/ml
2.95
16
118
13
179
0.73
0.50
1.4
1.6
—
—
—
0
0
13
179
0.73
0.50
1.4
1.5
—
—
—
0
0
31
253
1.23
0.48
1.1
1.2
—
2.07
—
0
11
27
218
1.24
0.46
3.7
3.2
—
—
—
0
0
47
402
1.17
0.46
1.1
1.1
—
—
—
0
0
61
533
1.15
0.46
1.3
1.3
—
—
—
0
0
74
656
1.13
0.45
4.0
4.2
1.60
1.66
%
0.04
68
578
22
174
1.27
0.44
1.0
2.2
—
—
—
0
0
22
174
1.27
0.44
1.0
2.2
—
—
—
0
0
22
174
1.27
0.44
1.0
2.2
—
—
—
0
0
22
174
1.27
0.44
1.0
2.2
—
—
—
0
0
59
516
1.15
0.44
1.2
1.2
27.69
7.80
u/ml
—
7
26
17
131
1.30
0.42
1.1
1.4
—
—
—
0
0
57
648
0.88
0.42
2.2
1.5
0.82
0.86
nmol/l
0.21
48
541
1134
11090
1.04
0.41
3.7
3.7
68.56
58.27
mg/l
0.64
771
7893
5
33
1.52
0.41
1.4
2.2
0.20
0.21
u/field
—
5
33
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
11
79
1.39
0.40
1.1
1.1
—
—
—
0
0
123
1131
1.09
0.40
1.8
1.7
0.26
0.34
mg/l
1.00
59
572
12
88
1.37
0.40
1.3
1.2
0.37
1.77
mmol/l
—
5
66
10
71
1.41
0.39
1.0
1.1
—
—
—
0
0
13
98
1.33
0.37
7.2
7.6
17.20
31.09
ug/l
—
8
77
15
116
1.29
0.37
1.4
1.7
8.23
9.52
ug/l
0.23
15
104
19
235
0.81
0.37
1.1
1.1
—
—
—
0
0
152
1421
1.07
0.35
2.5
3.6
71.74
60.17
mg/l
0.34
126
1212
22
181
1.22
0.34
1.1
1.4
—
—
—
0
0
6
44
1.36
0.34
1.2
1.1
—
—
—
0
0
16
127
1.26
0.33
2.1
2.7
0.63
0.60
mmol/l
0.51
16
127
88
807
1.09
0.33
1.7
1.6
—
—
—
0
0
22
182
1.21
0.33
2.0
2.3
—
—
—
0
0
44
388
1.14
0.32
1.3
1.5
—
—
—
0
0
10
74
1.35
0.32
1.0
1.1
—
—
—
0
0
151
1418
1.07
0.32
2.5
3.6
40.48
64.26
mg/l
1.22
125
1212
100
925
1.08
0.31
1.4
1.4
—
—
—
0
0
34
390
0.87
0.31
1.4
1.2
0.53
0.64
ratio
—
10
75
64
580
1.11
0.31
1.2
1.2
1.63
3.86
u/ml
—
8
40
27
230
1.18
0.31
1.1
1.2
—
140.00
—
0
8
7
96
0.73
0.30
1.0
1.0
—
—
—
0
0
52
466
1.12
0.30
4.7
4.9
9.39
11.48
pmol/l
1.09
52
466
16
129
1.24
0.30
1.2
1.1
46.80
370.97
ng/l
—
5
37
171
1807
0.94
0.30
5.0
3.8
25.08
24.88
mmol/l
0.32
162
1742
1156
11367
1.03
0.29
4.4
4.5
11.02
11.20
mg/mmol
0.03
751
7807
7
56
1.25
0.29
1.1
1.5
43.14
218.20
u/ml
—
7
51
10
130
0.77
0.29
1.4
1.0
—
—
—
0
0
51
566
0.90
0.29
1.3
1.4
10.16
23.85
e6/l
0.56
43
421
17
139
1.22
0.29
1.1
1.1
—
—
—
0
0
8
109
0.73
0.29
2.6
1.2
225.38
190.40
mmol/24h
—
8
109
31
355
0.87
0.28
1.7
1.3
248.22
269.29
pmol/l
0.24
23
289
8
63
1.27
0.27
1.8
2.1
—
—
—
0
0
52
574
0.90
0.27
1.4
1.5
1294.47
995.36
e6/l
0.12
43
452
29
252
1.15
0.27
1.6
2.0
1.64
1.21
u/field
0.22
14
141
8
65
1.23
0.27
1.8
2.1
—
—
—
0
0
94
876
1.08
0.26
1.9
1.6
—
—
—
0
0
9
74
1.22
0.25
1.2
1.5
—
—
—
0
0
26
226
1.15
0.25
2.3
2.7
30.44
36.98
mg/l
0.41
21
179
34
302
1.13
0.24
1.0
1.9
—
—
—
0
0
34
302
1.13
0.24
1.0
1.9
—
—
—
0
0
34
302
1.13
0.24
1.0
1.9
—
—
—
0
0
6
82
0.73
0.24
1.0
1.3
1.14
1.17
mmol/l
—
6
82
293
2831
1.04
0.24
1.9
1.8
1.58
1.66
%
1.12
244
2356
42
379
1.11
0.24
1.3
1.5
—
—
—
0
0
95
1012
0.94
0.23
1.9
1.9
3.18
3.27
mmol/l
0.34
71
753
63
582
1.08
0.23
1.2
1.2
9.81
3.72
u/ml
0.64
15
65
61
660
0.92
0.22
1.2
1.3
253.33
360.00
titre
—
6
43
21
181
1.16
0.22
1.1
1.4
—
—
—
0
0
39
431
0.90
0.22
1.4
1.2
1.43
1.42
g/l
0.16
39
431
35
314
1.12
0.22
1.4
1.3
284.52
279.37
mosm/kgh2o
0.55
25
240
0
12
0.00
0.21
0.0
1.1
—
2.04
—
0
6
0
12
0.00
0.21
0.0
1.1
—
32.67
—
0
6
5
43
1.16
0.21
2.8
3.9
36.00
42.09
umol/l
—
5
38
41
373
1.10
0.21
1.3
1.5
—
—
—
0
0
44
402
1.10
0.20
2.0
2.1
31.28
24.03
mg/l
0.50
16
135
360
3504
1.03
0.20
5.9
5.4
30.97
32.25
%
1.33
235
2336
21
240
0.87
0.20
1.2
1.3
—
141.30
—
0
23
0
14
0.00
0.20
0.0
1.2
—
178.22
—
0
9
82
771
1.07
0.20
1.2
1.2
0.20
0.77
u/ml
—
7
69
41
374
1.10
0.20
1.3
1.5
—
—
—
0
0
41
374
1.10
0.20
1.3
1.5
—
—
—
0
0
12
144
0.83
0.19
1.1
1.1
—
—
—
0
0
20
174
1.15
0.19
1.4
1.2
97.80
88.79
pmol/l
0.43
20
174
20
174
1.15
0.19
1.1
1.0
—
—
—
0
0
17
146
1.17
0.19
1.7
1.3
—
—
—
0
0
19
165
1.15
0.19
1.4
1.4
0.30
3.06
u/ml
2.32
13
112
42
385
1.09
0.19
1.6
1.5
—
—
—
0
0
17
147
1.16
0.18
1.2
1.1
—
—
—
0
0
46
425
1.08
0.18
1.1
1.1
146.44
36.82
iu/ml
0.53
18
85
23
204
1.13
0.18
1.3
1.2
9.68
10.40
mmol/l
0.41
23
190
32
291
1.10
0.17
1.5
2.0
—
1725.00
—
0
16
7
63
1.11
0.17
1.3
1.5
11.43
9.35
ug/l
—
7
63
17
148
1.15
0.17
1.4
1.7
41.75
39.48
g/l
1.04
17
148
36
330
1.09
0.16
1.2
1.4
0.30
0.24
nmol/l
—
5
33
34
371
0.92
0.16
2.4
3.2
—
—
—
0
0
8
68
1.18
0.16
1.0
1.5
—
—
—
0
0
27
244
1.11
0.16
1.5
1.5
—
—
—
0
0
20
224
0.89
0.15
1.1
1.1
—
—
—
0
0
12
102
1.18
0.15
1.0
1.2
—
—
—
0
0
133
1284
1.04
0.14
2.6
3.5
5.15
2.60
ratio
0.42
66
776
19
212
0.90
0.14
1.1
1.0
—
—
—
0
0
41
383
1.07
0.13
1.3
1.5
—
—
—
0
0
15
169
0.89
0.12
2.9
3.8
1.63
1.17
%
0.18
15
169
27
250
1.08
0.11
1.2
1.1
—
23.82
—
0
6
148
1520
0.97
0.11
2.3
2.2
3.45
3.60
ratio
0.74
122
1266
17
154
1.10
0.10
1.1
1.1
7.10
9.14
nmol/l
—
5
39
15
135
1.11
0.09
6.4
6.0
76.20
70.53
%
—
10
104
30
319
0.94
0.09
1.4
1.3
82145.50
115499.36
e6/l
0.20
20
218
79
764
1.03
0.09
1.7
1.6
24.49
26.88
u/ml
0.10
18
151
5
62
0.81
0.08
1.2
1.1
—
—
—
0
0
27
287
0.94
0.08
1.4
1.3
—
—
—
0
0
14
127
1.10
0.08
1.4
1.4
102.57
88.99
umol/l
—
7
71
6
70
0.86
0.07
1.3
1.2
10.00
13.44
mm/h
—
6
70
6
74
0.81
0.07
1.3
1.2
39.00
31.18
%
—
6
51
85
827
1.03
0.07
1.7
1.5
14047.00
16639.03
e6/l
0.29
64
572
7
83
0.84
0.07
1.1
1.1
—
—
—
0
0
78
801
0.97
0.06
2.8
3.5
1592.94
713.40
u/ml
0.29
70
743
41
394
1.04
0.06
1.6
1.6
25.84
33.43
ng/l
0.98
41
394
20
211
0.95
0.04
1.2
1.3
—
—
—
0
0
93
917
1.01
0.03
1.3
1.6
—
—
—
0
0
20
209
0.96
0.03
2.3
2.1
70.57
216.72
ug/min
—
7
57
25
241
1.04
0.02
1.5
1.5
—
—
—
0
0
11
103
1.07
0.02
1.0
1.6
1.24
13.56
nmol/l
1.48
11
89
102
1030
0.99
0.02
6.2
4.4
3.92
3.98
mmol/l
0.76
102
1016
34
332
1.02
0.01
1.5
1.6
—
—
—
0
0
94
939
1.00
0.00
2.3
2.3
116.25
110.81
ug/min
0.05
43
565
13
126
1.03
0.00
1.1
2.6
—
—
—
0
0
13
126
1.03
0.00
1.1
2.6
—
—
—
0
0
19
194
0.98
0.00
1.3
1.5
65.57
67.72
%
0.09
14
159
10
102
0.98
0.00
2.0
2.2
11.28
22.60
u/l
—
10
91
13
128
1.02
0.00
1.0
2.5
—
—
—
0
0
39
388
1.01
0.00
1.3
1.2
24.90
37.56
u/ml
—
7
25
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
7
77
0.91
0.00
1.6
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
1.43
—
0
6
6
66
0.91
-0.00
1.2
1.4
88.33
521.48
nmol/24h
—
6
66
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
70
1.00
-0.00
1.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
1.40
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint ERECTILE_DYSFUNCTION and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ERECTILE_DYSFUNCTION | 0.84 [0.78, 0.9] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.039 |
During the follow-up period (1.1.1998 — 31.12.2019), 2515 out of 10411 males with ERECTILE_DYSFUNCTION died.
Mortality risk
Mortality risk for people of age
years, who have ERECTILE_DYSFUNCTION.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.186% |
| 5 | No data | 0.921% |
| 10 | No data | 2.428% |
| 15 | No data | 4.881% |
| 20 | No data | 8.63% |
Relationships between endpoints
↥Index endpoint: ERECTILE_DYSFUNCTION – Erectile dysfunction
GWS hits: 5
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data